Early use of non-steroidal anti-inflammatory drugs in COVID-19 might reverse pathogenesis, prevent complications and improve clinical outcomes

Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie
Mina T Kelleni

Abstract

The pathogenesis of Coronavirus disease 2019 is still obscure and the need for exploration of possible mechanisms to suggest drugs based on knowledge should never be delayed. In this manuscript, we present a novel theory to explain the pathogenesis of COVID-19; lymphocyte distraction theory upon which the author has used, in a preprinted protocol, non-steroidal anti-inflammatory drugs (NSAIDs); diclofenac potassium, ibuprofen and ketoprofen, successfully to treat COVID-19 patients. Furthermore, we agree with a recommendation that glucocorticoids should not be used routinely for COVID-19 patients and suggested to be beneficial only for patients with late acute respiratory distress syndrome. A clinical proof of ibuprofen safety in COVID-19 has been published by other researchers and we suggest that early administration of NSAIDs, including ibuprofen, in COVID-19 is not only safe but it might also prevent COVID-19 complications and this manuscript explains some of the suggested associated protective mechanisms.

References

Apr 1, 1978·Annals of Internal Medicine·C G Craddock
Apr 12, 2003·Critical Care Medicine·B Taylor Thompson
Mar 24, 2004·Inflammopharmacology·Birgit Winther, Niels Mygind
May 19, 2004·European Journal of Clinical Investigation·N S PanesarJ J Y Sung
Jul 24, 2012·JAMA : the Journal of the American Medical Association·Nicholas I PatonUNKNOWN Hydroxychloroquine Trial Team
Mar 15, 2020·The Lancet. Respiratory Medicine·Lei FangMichael Roth
Mar 29, 2020·The Journal of Clinical Investigation·Savannah F Pedersen, Ya-Chi Ho
Apr 1, 2020·Signal Transduction and Targeted Therapy·Li TanHongming Miao
Apr 4, 2020·Chest·Mohit Sodhi, Mahyar Etminan
Apr 11, 2020·Antiviral Research·Erwan SallardNathan Peiffer-Smadja
Apr 12, 2020·Clinical Rheumatology·Durga Prasanna MisraOlena Zimba
Apr 17, 2020·Signal Transduction and Targeted Therapy·Li TanHongming Miao
May 4, 2020·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Mina T Kelleni
Jun 13, 2020·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Nicholas MooreCecile Droz
Jun 15, 2020·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·E RinottI Youngster
Jul 1, 2020·The New England Journal of Medicine·Leora R FeldsteinUNKNOWN CDC COVID-19 Response Team
Jul 8, 2020·International Journal of Antimicrobial Agents·Firouzé Bani-SadrDamien Jolly
Jul 28, 2020·Nature·Carolina LucasAkiko Iwasaki
Sep 3, 2020·JAMA : the Journal of the American Medical Association·UNKNOWN WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working GroupJohn C Marshall
Sep 3, 2020·JAMA : the Journal of the American Medical Association·Bruno M TomaziniUNKNOWN COALITION COVID-19 Brazil III Investigators

❮ Previous
Next ❯

Citations

Jan 27, 2021·Drug Development Research·Parteek PrasherRavi Gunupuru
May 1, 2021·Pharmaceutics·Matteo PuccettiStefano Giovagnoli
Aug 3, 2021·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Nicholas MooreCécile Droz-Perroteau
Aug 17, 2021·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Neha DabholkarGautam Singhvi
Oct 7, 2021·Environmental Science and Pollution Research International·Smita KumariRashmi K Ambasta

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Expert Review of Respiratory Medicine
Frideriki PoutoglidouDimitrios Kouvelas
American Journal of Therapeutics
Gurusaravanan Kutti SridharanVenkata R P Rokkam
Drug Safety : an International Journal of Medical Toxicology and Drug Experience
Nicholas MooreCecile Droz
© 2021 Meta ULC. All rights reserved